Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genito-Urinary Cancer”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableStudy completedNCT02067754
What this trial is testing

Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer

Who this might be right for
Gastric Cancer
Samsung Medical Center 396
Not applicableLooking for participantsNCT07324798
What this trial is testing

Adaptive Radiotherapy for Genitourinary Cancers

Who this might be right for
Prostate Cancer (Post Prostatectomy)Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Large-scale testing (Phase 3)Looking for participantsNCT06717711
What this trial is testing

Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers

Who this might be right for
Prostate CarcinomaErectile FunctionGenito Urinary Cancer
Regina Elena Cancer Institute 158
Not applicableStudy completedNCT02153801
What this trial is testing

Genito Urinary Function With High or Low Inferior Mesenteric Artery Ligation in Laparoscopic Anterior Rectal Resection

Who this might be right for
Genito Urinary Function Evaluation
Niguarda Hospital 212
Not applicableWithdrawnNCT03238053
What this trial is testing

Laser Treatment of Genito-urinary Syndrome in Women

Who this might be right for
Laser-Induced ScarBreast CancerEndometrial Cancer+3 more
Herning Hospital
Early research (Phase 1)Active Not RecruitingNCT05902520
What this trial is testing

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Who this might be right for
HNSCCMelanomaGynecologic Cancer+3 more
AgonOx, Inc. 18
Not applicableStudy completedNCT01278537
What this trial is testing

Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery

Who this might be right for
Cancer
Charite University, Berlin, Germany 690
Not applicableUnknownNCT05421377
What this trial is testing

Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 2

Who this might be right for
Lower Limb Lymphedema
KU Leuven 120
Not applicableLooking for participantsNCT07524114
What this trial is testing

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Who this might be right for
Breast CancerLung CancerMelanoma+7 more
University Health Network, Toronto 7,000
Not applicableLooking for participantsNCT06464536
What this trial is testing

Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy

Who this might be right for
Taxane-induced Peripheral Neuropathy
St.Gallen University of Applied Sciences 114
Not applicableActive Not RecruitingNCT05629065
What this trial is testing

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

Who this might be right for
Breast CancerGastrointestinal CancerGynecologic Cancer+2 more
Dana-Farber Cancer Institute 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT03333616
What this trial is testing

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Who this might be right for
Genitourinary CancerAdrenocortical CarcinomaNon-urothelial Bladder+5 more
Dana-Farber Cancer Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT04624399
What this trial is testing

Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer

Who this might be right for
Urogenital Cancer
Queen Mary University of London 58
Early research (Phase 1)Study completedNCT01375699
What this trial is testing

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Who this might be right for
Breast CancerGastrointestinal CancerGenitourinary Cancer+2 more
Virginia Commonwealth University 26
Large-scale testing (Phase 3)Study completedNCT00631371
What this trial is testing

Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Who this might be right for
Renal Cell Carcinoma
Pfizer 791
Not applicableActive Not RecruitingNCT05509751
What this trial is testing

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

Who this might be right for
Lung CancerGastro-intestinal CancerGenito-Urinary Cancer+3 more
Martine Puts 60
Not applicableActive Not RecruitingNCT03794635
What this trial is testing

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

Who this might be right for
Metastatic CancerLocally Advanced CancerThoracic Cancer+3 more
Memorial Sloan Kettering Cancer Center 45
Very early researchNot Yet RecruitingNCT07389525
What this trial is testing

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Who this might be right for
Gastrointestinal NeoplasmsGenitourinary CancerThoracic Cancer+2 more
Indiana University 80
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Not applicableStudy completedNCT03887091
What this trial is testing

Personal Web Page In Clinical Trial Participant Education

Who this might be right for
Prostate CancerKidney CancerGenitourinary Cancer
Dana-Farber Cancer Institute 99
Load More Results